TERM ID="NYU_TERM_1" STRING="(TD-B)-fold enhancement" FREQUENCY=1 START=1222 END=1245 LEMMA="(TD-B)-FOLD ENHANCEMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="E-TPGS" FREQUENCY=1 START=678 END=684 LEMMA="E-TPG" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_3" STRING="Kolliphor" FREQUENCY=1 START=667 END=676 LEMMA="KOLLIPHOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_4" STRING="Nanocrystal formulations" FREQUENCY=2 START=425 END=449 LEMMA="NANOCRYSTAL FORMULATION" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_5" STRING="Nanocrystal formulations" FREQUENCY=2 START=1368 END=1392 LEMMA="NANOCRYSTAL FORMULATION" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_6" STRING="Nanocrystals" FREQUENCY=1 START=1057 END=1069 LEMMA="NANOCRYSTAL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_7" STRING="Nanocrystals TD-A" FREQUENCY=1 START=1057 END=1074 LEMMA="TD-A NANOCRYSTAL" LEMMA_FREQUENCY=1 HEAD_TERM="TD-A" HEAD_LEMMA="TD-A"
TERM ID="NYU_TERM_8" STRING="Oral hypoglycemic activity" FREQUENCY=1 START=971 END=997 LEMMA="ORAL HYPOGLYCEMIC ACTIVITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_9" STRING="Soluplus" FREQUENCY=1 START=628 END=636 LEMMA="SOLUPLUS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_10" STRING="TD-A" FREQUENCY=2 START=1070 END=1074 LEMMA="TD-A" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_11" STRING="TD-A" FREQUENCY=2 START=1209 END=1213 LEMMA="TD-A" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_12" STRING="TD-B" FREQUENCY=1 START=1079 END=1083 LEMMA="TD-B" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="Wistar rats" FREQUENCY=1 START=958 END=969 LEMMA="WISTAR RAT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_14" STRING="ability" FREQUENCY=1 START=556 END=563 LEMMA="ABILITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_15" STRING="anti-diabetic" FREQUENCY=1 START=357 END=370 LEMMA="ANTI-DIABETIC" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="dissolution velocity" FREQUENCY=1 START=218 END=238 LEMMA="DISSOLUTION VELOCITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="dissolving repaglinide" FREQUENCY=1 START=14 END=36 LEMMA="DISSOLVING REPAGLINIDE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_18" STRING="fasted/fed state" FREQUENCY=1 START=1321 END=1337 LEMMA="FASTED/FED STATE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="fasted/fed state variability" FREQUENCY=1 START=289 END=317 LEMMA="FASTED/FED STATE VARIABILITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_20" STRING="fasted/fed state variability of repaglinide" FREQUENCY=1 START=289 END=332 LEMMA="REPAGLINIDE FASTED/FED STATE VARIABILITY" LEMMA_FREQUENCY=1 HEAD_TERM="fasted/fed state variability" HEAD_LEMMA="FASTED/FED STATE VARIABILITY"
TERM ID="NYU_TERM_21" STRING="formulation stability" FREQUENCY=1 START=579 END=600 LEMMA="FORMULATION STABILITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="gastric fluid" FREQUENCY=1 START=825 END=838 LEMMA="GASTRIC FLUID" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_23" STRING="hypoglycemic activity" FREQUENCY=1 START=1435 END=1456 LEMMA="HYPOGLYCEMIC ACTIVITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_24" STRING="min" FREQUENCY=2 START=1489 END=1492 LEMMA="MIN" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_25" STRING="min" FREQUENCY=2 START=1568 END=1571 LEMMA="MIN" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_26" STRING="nanocrystals" FREQUENCY=1 START=1277 END=1289 LEMMA="NANOCRYSTAL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_27" STRING="nanotechnology" FREQUENCY=1 START=409 END=423 LEMMA="NANOTECHNOLOGY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_28" STRING="oral absorption enhancer" FREQUENCY=1 START=700 END=724 LEMMA="ORAL ABSORPTION ENHANCER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_29" STRING="oral bioavailability" FREQUENCY=2 START=248 END=268 LEMMA="ORAL BIOAVAILABILITY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_30" STRING="oral bioavailability" FREQUENCY=2 START=1253 END=1273 LEMMA="ORAL BIOAVAILABILITY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_31" STRING="oral bioavailability of nanocrystals" FREQUENCY=1 START=1253 END=1289 LEMMA="NANOCRYSTAL ORAL BIOAVAILABILITY" LEMMA_FREQUENCY=1 HEAD_TERM="oral bioavailability" HEAD_LEMMA="ORAL BIOAVAILABILITY"
TERM ID="NYU_TERM_32" STRING="particle size" FREQUENCY=1 START=613 END=626 LEMMA="PARTICLE SIZE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_33" STRING="pharmacokinetics behavior" FREQUENCY=1 START=123 END=148 LEMMA="PHARMACOKINETICS BEHAVIOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_34" STRING="repaglinide" FREQUENCY=5 START=321 END=332 LEMMA="REPAGLINIDE" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_35" STRING="repaglinide" FREQUENCY=5 START=867 END=878 LEMMA="REPAGLINIDE" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_36" STRING="repaglinide" FREQUENCY=5 START=1185 END=1196 LEMMA="REPAGLINIDE" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_37" STRING="repaglinide" FREQUENCY=5 START=1355 END=1366 LEMMA="REPAGLINIDE" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_38" STRING="repaglinide" FREQUENCY=5 START=1546 END=1557 LEMMA="REPAGLINIDE" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_39" STRING="saturation solubility" FREQUENCY=1 START=1124 END=1145 LEMMA="SATURATION SOLUBILITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_40" STRING="stabilizer" FREQUENCY=1 START=652 END=662 LEMMA="STABILIZER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_41" STRING="streptozotocin-induced diabetic rats" FREQUENCY=1 START=1019 END=1055 LEMMA="STREPTOZOTOCIN-INDUCED DIABETIC RAT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_42" STRING="vitro dissolution profiles" FREQUENCY=1 START=729 END=755 LEMMA="VITRO DISSOLUTION PROFILE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_43" STRING="vivo pharmacokinetics" FREQUENCY=1 START=883 END=904 LEMMA="VIVO PHARMACOKINETIC" LEMMA_FREQUENCY=1
